Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;54(9):2568-72.
doi: 10.1194/jlr.P040022. Epub 2013 Jul 4.

Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation

Yosuke Suzuki  1 , Hiroki Itoh, Fuminori Sato, Kanako Kawasaki, Yukie Sato, Takashi Fujioka, Yuhki Sato, Keiko Ohno, Hiromitsu Mimata, Satoshi Kishino
Affiliations

Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation

Yosuke Suzuki et al. J Lipid Res. 2013 Sep.

Abstract

Several previous studies have shown that renal failure decreases not only renal elimination but also metabolic clearance of drugs, particularly those metabolized by CYP3A. However, whether recovery of renal function results in recovery of hepatic CYP3A activity remains unknown. In this study, we evaluated the effect of renal function on CYP3A activity after kidney transplantation in patients with end-stage renal disease (ESRD) by measuring the change in CYP3A activity using plasma concentration of 4β-hydroxycholesterol as a biomarker. The study enrolled 13 patients with ESRD who underwent the first kidney allograft transplantation. Morning blood samples were collected before and 3, 7, 10, 14, 21, 30, 60, 90, 120, 150 and 180 days after kidney transplantation. Plasma concentration of 4β-hydroxycholesterol was measured using GC-MS. Compared with before kidney transplantation, creatinine clearance increased significantly from day 3 after kidney transplantation and stabilized thereafter. Plasma concentration of 4β-hydroxycholesterol was elevated significantly on days 90 and 180 after kidney transplantation. In conclusion, this study suggests the recovery of CYP3A activity with improvement in renal function after kidney transplantation in patients with ESRD.

Keywords: CYP3A activity; end-stage renal disease; plasma; renal failure.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Change in creatinine clearance over time in patients with end-stage renal disease after kidney transplantation. Data are presented as mean ± SD, n = 13. †P < 0.01 versus before transplantation.
Fig. 2.
Fig. 2.
Change in plasma concentration of 4β-hydroxycholesterol over time in patients with end-stage renal disease after kidney transplantation. Data are presented as mean ± SD, n = 13. *P < 0.05 versus before transplantation.
See this image and copyright information in PMC

References

    1. Uchida N., Kurata N., Shimada K., Nishimura Y., Yasuda K., Hashimoto M., Uchida E., Yasuhara H. 1995. Changes of hepatic microsomal oxidative drug metabolizing enzymes in chronic renal failure (CRF) rats by partial nephrectomy. Jpn. J. Pharmacol. 68: 431–439. - PubMed
    1. Leblond F. A., Giroux L., Villeneuve J. P., Pichette V. 2000. Decreased in vivo metabolism of drugs in chronic renal failure. Drug Metab. Dispos. 28: 1317–1320. - PubMed
    1. Leblond F., Guévin C., Demers C., Pellerin I., Gascon-Barré M., Pichette V. 2001. Downregulation of hepatic cytochrome P450 in chronic renal failure. J. Am. Soc. Nephrol. 12: 326–332. - PubMed
    1. Rege B., Krieg R., Gao N., Sarkar M. A. 2003. Down-regulation of hepatic CYP3A in chronic renal insufficiency. Pharm. Res. 20: 1600–1606. - PubMed
    1. Naud J., Michaud J., Beauchemin S., Hébert M. J., Roger M., Lefrancois S., Leblond F. A., Pichette V. 2011. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats. Drug Metab. Dispos. 39: 1363–1369. - PubMed